Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N4VN
|
|||
| Former ID |
DNCL002864
|
|||
| Drug Name |
INGAP peptide
|
|||
| Indication | Type-1/2 diabetes [ICD-11: 5A10-5A11] | Phase 2 | [1] | |
| Company |
Exsulin
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Phosphofructokinase 2 (PFK2) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Liver carbohydrates metabolism: A new islet-neogenesis associated protein peptide (INGAP-PP) target. Peptides. 2018 Mar;101:44-50. | |||
| REF 2 | A Pentadecapeptide Fragment of Islet Neogenesis-Associated Protein Increases Beta-Cell Mass and Reverses Diabetes in C57BL/6J Mice. Ann Surg. 2004 November; 240(5): 875-884. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.